• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    博

    博士伦

    Bausch & Lomb
    企业
    727论文总数
    1.3万引用总数

    博士伦是一家全球性的眼睛保健公司,致力于通过创新的科技与技术,让消费者看得更好、形象更好、感觉更好。博士伦成立于1853年,目前年度营业额近二十亿美元,在全球50多个国家聘有约11,500名员工,产品行销全球一百多个国家,其全球总部设在美国纽约州罗彻斯特市。

    论文量&引用量时间轴

    机构学者

    论文(727)

    年份
    起
    –
    止
    排序
    1Real-World Evaluation of Patient Satisfaction and Experience with a Novel Daily Disposable Contact Lens
    Kriti Bhagat,Marjorie J. Rah
    2026INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2026)
    引用
    AI阅读
    加入学术空间
    2Halo Characterization of Two Extended Range of Vision Intraocular Lenses
    Juan Antonio Azor Moron,Maria S. Millan,Fidel Vega,Jesus Armengol,Francisco Alba-Bueno
    2026INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2026)
    引用
    AI阅读
    加入学术空间
    3Global Unmet Needs in Dry Eye: A Comparative Assessment Across the United States and Five International Populations
    Robert Ryan, Piotr Wozniak,Marc Labetoulle,Eric Donnenfeld
    2026INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2026)
    引用
    AI阅读
    加入学术空间
    412-Month Visual and Safety Outcomes of the ELIOS Procedure with Cataract Surgery in Primary Open-Angle Glaucoma
    Steven Sarkisian,Mark Gallardo,George Reiss, Andy Lee,Paul Singh, Navaneet Borisuth, Mohamed Yassine, Kelly Swaim,Cathleen McCabe, Yi-Jing Duh, Hsin Yi Ling, Rupali Nangia,

    Purpose: To characterize early safety and visual outcomes through 12 months following combined phacoemulsification and ELIOS excimer laser trabeculostomy procedure in patients with mild-to-moderate primary open-angle glaucoma (POAG). Setting: Conducted at 20 US sites. Design: Prospective, multicenter, non-randomized clinical trial (NCT04899063). Methods: Adults aged ≥45 years with cataract and mild-to-moderate POAG underwent phacoemulsification with intraocular lens implantation followed immediately by the ELIOS procedure. Corrected distance visual acuity (CDVA), pachymetry, endothelial cell density (ECD), visual field measurements, and adverse events (AEs) were reported up to 12 months. Results: A total of 318 patients underwent the procedure; mean±SD age was 70.3±7.3 years, 172 (54.1%) were female, and 263 (82.7%) were White. Five intraoperative AEs were reported during cataract procedure and none during ELIOS procedure. Visual recovery was rapid and sustained: at month 12, all patients achieved CDVA 20/40 or better; CDVA was <1 line of baseline in 28.0% of patients and improved by ≥1 line in 214 (69.8%), and no losses ≥2 lines. Corneal edema occurred predominantly early and resolved without sequelae. ECD loss occurred early then stabilized; median change and median percent change in ECD at month 12 were −237.0 cells/mm 2 and −9.10%, respectively. Through 12 months, 73 postoperative ocular AEs were reported in 17.3% of patients; the most common AEs were anterior chamber cell/flare requiring increased or reinitiated steroid therapy (5.7%), and worsening of visual field mean deviation by ≥2.5 dB from baseline (4.4%). Conclusions: Combined phacoemulsification-ELIOS was associated with a safety profile consistent with published outcomes following phacoemulsification alone, with predominantly early, self-limited postoperative events.

    2026Journal of Cataract &amp Refractive Surgery(2026)
    引用
    AI阅读
    加入学术空间
    5A Phase 3 Randomized Trial of a Novel Brimonidine Tartrate Ophthalmic Solution with Sodium Hyaluronate
    Shane Kannarr, Alfred M. Kubong, Matt Walker, Mayssa Attar
    2026INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 727 篇论文

    合作机构(100)

    Rochester University合作论文 25
    科罗拉多州立大学合作论文 7
    卡塔尼亚大学合作论文 6
    路易斯维尔大学合作论文 6
    博洛尼亚大学合作论文 5
    阿拉巴马大学伯明翰分校合作论文 5
    杜克大学合作论文 5
    克拉克森大学合作论文 5
    密西西比大学合作论文 5
    俄亥俄州立大学合作论文 5

    机构统计